Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Abbott, Absorb bioresorbable stent, BVS, FDA advisory panel approval
Feature | Stents Bioresorbable | March 15, 2016 | Dave Fornell
March 15, 2016 — An independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0,...
Biotronik, Magnesium Elektron, bioresorbable magnesium coronary scaffold, partner

Specially designed extrusion equipment at Magnesium Elektron’s purpose-built facility in England produces wire made from SynerMag bioresorbable magnesium alloy. Photo courtesy of Business Wire.

News | Stents Bioresorbable | March 11, 2016
March 11, 2016 — Magnesium Elektron, developer, manufacturer and supplier of high-performance magnesium alloys,...
Biotronik, BIOSCIENCE trial, Orsiro hybrid DES, drug-eluting stent, STEMI heart attack patients
News | Stents Drug Eluting | March 07, 2016
March 7, 2016 — Biotronik announced publication of results from the BIOSCIENCE trial in the journal EuroIntervention....
CREST trial results, New England Journal of Medicine, stenting, endarterectomy, carotid artery stenosis
News | Cath Lab | March 04, 2016
March 4, 2016 — Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are...
Intact Vascular, Tack Endovascular System

The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.

Feature | Peripheral Artery Disease (PAD) | February 22, 2016 | Dave Fornell
It is estimated that more than 10 million people in the United States are affected by peripheral arterial disease (PAD...
peripheral stents, market report 2020, MedMarket Diligence
News | Stents Peripheral | February 19, 2016
February 19, 2016 — Peripheral stents will account for over $4.6 billion in worldwide sales by 2020, according to a new...
Biotronik, Maquet, partnership, peripheral vascular devices, U.S. market, Astron self-expanding iliac stent
Technology | Stents Peripheral | February 17, 2016
February 17, 2016 — Biotronik announced a partnership with Maquet Medical Systems USA to distribute Biotronik...
CeloNova, COBRA REDUCE trial, first patient enrolled, Cobra PzF coronary stent
News | Stents | February 10, 2016
February 10, 2016 — CeloNova BioSciences Inc. announced this week that the first patient has been enrolled in its COBRA...
Stentys, commercialization, BTK stent, below-the-knee arteries
News | Stents Peripheral | February 08, 2016
February 8, 2016 — Stentys announced the first distribution agreements for its drug-eluting stent for treating below-...
Medtronic, CE Mark, Resolute Onyx DES, drug-eluting stent, expanded sizes and indications
News | Stents Drug Eluting | February 02, 2016
February 2, 2016 — Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the...
TOBA-BTK study, six-month results, LINC 2016, Tack Endovascular System
News | Peripheral Artery Disease (PAD) | January 29, 2016
January 29, 2016 — Intact Vascular Inc. announced that positive six-month results from its Tack Optimized Balloon...
Blog | January 20, 2016
At the beginning of each year, I always try to determine what the next big cardiovascular technology advances to watch...
Abbott, Absorb, BVS, FDA review, FDA panel

The Abbott Absorb BVS.

News | Cath Lab | January 20, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer...
News | Stents Drug Eluting | January 08, 2016
January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient...
Biotronik Astron stent
Technology | Stents Peripheral | December 31, 2015
December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-...